ITCI Annual Net Margin
-30.22%
+72.64%+70.62%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual net profit margin is -30.22%, with the most recent change of +72.64% (+70.62%) on December 31, 2023. During the last 3 years, it has risen by +977.31% (+97.00%). ITCI annual net margin is now at all-time high.ITCI Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Net Margin
-15.03%
-4.97%-49.40%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly net profit margin is -15.03%, with the most recent change of -4.97% (-49.40%) on September 30, 2024. Over the past year, it has increased by +4.25% (+22.04%). ITCI quarterly net margin is now -49.40% below its all-time high of -10.06%, reached on June 30, 2024.ITCI Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.6% | +22.0% |
| 3 y3 years | +97.0% | +22.0% |
| 5 y5 years | - | +22.0% |
ITCI Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.3% | -49.4% | +95.5% |
| 5 y | 5-year | at high | +97.0% | -49.4% | +99.7% |
| alltime | all time | at high | +100.0% | -49.4% | +100.0% |
Intra-Cellular Therapies Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -15.03%(+49.4%) |
| June 2024 | - | -10.06%(-4.5%) |
| Mar 2024 | - | -10.53%(-51.5%) |
| Dec 2023 | -30.22%(-70.6%) | -21.73%(+12.7%) |
| Sept 2023 | - | -19.28%(-50.4%) |
| June 2023 | - | -38.85%(-16.5%) |
| Mar 2023 | - | -46.50%(-7.6%) |
| Dec 2022 | -102.86%(-70.4%) | -50.35%(-32.4%) |
| Sept 2022 | - | -74.45%(-52.7%) |
| June 2022 | - | -157.25%(-24.2%) |
| Mar 2022 | - | -207.51%(-38.2%) |
| Dec 2021 | -347.73%(-65.5%) | -336.00%(-5.6%) |
| Sept 2021 | - | -355.96%(-1.6%) |
| June 2021 | - | -361.68%(+6.8%) |
| Mar 2021 | - | -338.53%(-30.8%) |
| Dec 2020 | -1007.53% | -489.35%(-34.7%) |
| Sept 2020 | - | -748.90%(-78.0%) |
| June 2020 | - | -3396.38%(-36.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -5372.21%(-99.1%) |
| Dec 2017 | -39.77 K%(+13.0%) | -597.60 K%(+703.6%) |
| Sept 2017 | - | -74.37 K%(+380.4%) |
| June 2017 | - | -15.48 K%(-45.2%) |
| Mar 2017 | - | -28.27 K%(+0.7%) |
| Dec 2016 | -35.21 K%(-89.7%) | -28.08 K%(-96.0%) |
| Sept 2016 | - | -693.84 K%(+5040.5%) |
| June 2016 | - | -13.50 K%(-64.0%) |
| Dec 2015 | -341.80 K%(+5997.9%) | - |
| June 2015 | - | -37.48 K%(-94.4%) |
| Mar 2015 | - | -672.30 K%(+1497.1%) |
| Dec 2014 | -5605.28%(+471.0%) | -42.09 K%(+716.3%) |
| Sept 2014 | - | -5156.58%(+149.4%) |
| June 2014 | - | -2067.86%(-23.6%) |
| Mar 2014 | - | -2707.77%(+178.7%) |
| Dec 2013 | -981.67%(+84.5%) | -971.66%(+32.1%) |
| Sept 2013 | - | -735.32% |
| Dec 2012 | -532.10% | - |
FAQ
- What is Intra-Cellular Therapies annual net profit margin?
- What is the all time high annual net margin for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual net margin year-on-year change?
- What is Intra-Cellular Therapies quarterly net profit margin?
- What is the all time high quarterly net margin for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly net margin year-on-year change?
What is Intra-Cellular Therapies annual net profit margin?
The current annual net margin of ITCI is -30.22%
What is the all time high annual net margin for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual net profit margin is -30.22%
What is Intra-Cellular Therapies annual net margin year-on-year change?
Over the past year, ITCI annual net profit margin has changed by +72.64% (+70.62%)
What is Intra-Cellular Therapies quarterly net profit margin?
The current quarterly net margin of ITCI is -15.03%
What is the all time high quarterly net margin for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly net profit margin is -10.06%
What is Intra-Cellular Therapies quarterly net margin year-on-year change?
Over the past year, ITCI quarterly net profit margin has changed by +4.25% (+22.04%)